Skip to content

Wingstop WING Subpart F income

Subpart F income at other companies

Baxter International logo
Baxter InternationalBAX
$4.5M-30.8%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$24.35M
GE Vernova logo
GE VernovaGEV
$20.25M
GE Vernova logo
GE VernovaGEV
2.9%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-2.1%
Cadence Design Systems logo
Cadence Design SystemsCDNS
1.4%

Other financials

Income statement

See full
Revenue$183.7M+7.4%
Gross profit$159.0M+7.3%
Operating income$50.4M+31.7%
Net income$29.9M-67.6%
EPS (diluted)$1.08-66.7%

Balance sheet

See full
Cash & equivalents$128.8M-48.8%
Total debt$1.3B+0.2%
Total equity-$799.2M-11.8%
Total assets$648.9M-6.9%

Cash flow

See full
Operating cash flow$61.4M+143%
CapEx$17.7M+121%
Free cash flow$43.7M+153%

Valuation

See full
Market cap$4.41B-34.1%

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin27%+2.2pp
Net margin15.8%-10.7pp
FCF margin19.7%+4.6pp

Returns & leverage

See full
Current ratio2.2×-1.3×

Where this comes from

Reported directly by Wingstop in its filing.

Tagged under the XBRL concept wing:EffectiveIncomeTaxRateReconciliationSubpartFIncomeAmount.

The official record: Wingstop’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wingstop's subpart f income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wingstop's subpart f income?
Wingstop (WING) reported subpart f income of $1.76M in Q4 2025.
What does subpart f income mean?
This metric tracks the income generated by foreign subsidiaries that is subject to immediate U.S. taxation under Subpart F rules. It identifies passive or specific types of foreign-source income that cannot be deferred for tax purposes. This is critical for evaluating the tax efficiency of the company's international corporate structure.